about
Exercise-related Brugada pattern and monomorphic ventricular tachycardia in a patient with Brugada syndrome: interplay between body temperature, haemodynamics and vagal activity.Role of the burden of premature atrial contractions during the blanking period following second-generation cryoballoon ablation in predicting late recurrences of atrial arrhythmias.Second-generation cryoballoon ablation in the setting of left common pulmonary veins: Procedural findings and clinical outcome.Comparison of the Incidences of Complications After Second-Generation Cryoballoon Ablation of Atrial Fibrillation Using Vitamin K Antagonists Versus Novel Oral Anticoagulants.Repeat procedures after second-generation cryoballoon ablation as an index procedure for persistent atrial fibrillation: one-year follow-up.Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience.One-year follow-up after second-generation cryoballoon ablation for atrial fibrillation in a large cohort of patients: a single-centre experience.Long-Term Follow-Up of Probands With Brugada Syndrome.Anatomic predictors of phrenic nerve injury in the setting of pulmonary vein isolation using the 28-mm second-generation cryoballoon.On the Quest for the Best Freeze: Predictors of Late Pulmonary Vein Reconnections After Second-Generation Cryoballoon Ablation.Prevalence and Clinical Impact of Early Repolarization Pattern and QRS-Fragmentation in High-Risk Patients With Brugada Syndrome.Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: Predictive role of atrial arrhythmias occurring in the blanking period on the incidence of late recurrences.Fluoroscopic position of the second-generation cryoballoon during ablation in the right superior pulmonary vein as a predictor of phrenic nerve injury.Waking up a sleeping volcano: activation of an accessory pathway after aortic valve surgery.Transcatheter device closure of atrial septal defects in patients above age 60.Second generation cryoballoon ablation for atrial fibrillation in young adults: midterm outcome in patients under 40 years of age.Cryoballoon ablation during atrial fibrillation is associated with faster temperature drop and lower freezing temperatures.Improved visualisation of real-time recordings during third generation cryoballoon ablation: a comparison between the novel short-tip and the second generation device.Incidence of real-time recordings of pulmonary vein potentials using the third-generation short-tip cryoballoon.Impact on Clinical Outcome of Premature Interruption of Cryoenergy Delivery Due to Phrenic Nerve Palsy During Second Generation Cryoballoon Ablation for Paroxysmal Atrial Fibrillation.Incidence and characteristics of complications in the setting of second-generation cryoballoon ablation: A large single-center study of 500 consecutive patients.Cryoballoon ablation in the presence of a large occlutech device.Repeat procedures using the second-generation cryoballoon for recurrence of atrial fibrillation after initial ablation with conventional radiofrequency.Single freeze strategy with the second- generation cryballoon for atrial fibrillation: a multicenter international retrospective analysis in a large cohort of patients.Single freeze per vein strategy with the second-generation cryoballoon for atrial fibrillation: a propensity score-matched study between 180- and 240-s application time in a large cohort of patients.Atrial fibrillation ablation with the second generation cryoballoon: Multicenter propensity score matched comparison between freezing strategies.Phrenic nerve injury during right inferior pulmonary vein ablation with the second-generation cryoballoon: clinical, procedural, and anatomical characteristics.Acute pericarditis following second-generation cryoballoon ablation for atrial fibrillation.Second-generation cryoballoon ablation without the use of real-time recordings: A novel strategy based on a temperature-guided approach to ablation.Learning curve using the second-generation cryoballoon ablation.Role of Electrocardiographic Tpeak-Tend for the Prediction of Ventricular Arrhythmic Events in the Brugada Syndrome.Single 3-Minute versus Double 4-Minute Freeze Strategy for Second-Generation Cryoballoon Ablation: A Single-Center Experience.Long-Term Performance of the Riata/ST Implantable Cardioverter-Defibrillator Lead.Second-Generation Cryoballoon Ablation in the Setting of Lone Paroxysmal Atrial Fibrillation: Single Procedural Outcome at 12 Months.Anatomical and procedural predictors of pulmonary vein stenosis in the setting of second-generation cryoballoon ablation.Midterm clinical outcomes of concomitant thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation: a single-centre experience.Complications in the setting of percutaneous atrial fibrillation ablation using radiofrequency and cryoballoon techniques: A single-center study in a large cohort of patients.Anatomical variation requiring simultaneous isolation of all pulmonary veins using a box lesion set.Efficacy and safety of the second generation cryoballoon ablation for the treatment of paroxysmal atrial fibrillation in patients over 75 years: a comparison with a younger cohort.Long-term outcome of pulmonary vein isolation in patients with paroxysmal atrial fibrillation and Brugada syndrome.
P50
Q33165859-D19F5B92-1B06-4F6D-9993-08DAB35BDED5Q38690119-2B1F164C-3CC8-403C-9BE4-853765E90368Q38720295-68F79B9C-0E87-44AA-8345-2C7E9253F681Q38770256-63D5D7D3-EAC4-4178-AF07-B66C9D0AAB67Q39453064-C70FC2B1-A3F2-4802-9EB8-88B184648FE6Q39985226-4F242908-9C94-401E-99D9-A74C32DC85EFQ40170297-52DCA9C8-BFE2-4D2A-A187-4B6FD152C234Q40301613-52D26661-986C-4F1E-93EC-E00A5DE02D9CQ40316033-4AD4122B-DC19-4FA6-B109-4424BDAD04BBQ40363557-A4B29831-B659-4F12-87E2-510B3A8288B6Q40608735-DF8316D2-DE66-442F-8E0B-07783A83AD13Q41004692-C2191D51-1668-4513-8FF6-DBB60994F6DBQ41091352-4622D967-D900-4E51-AE31-2824BFB2427BQ41955306-139375F1-9F91-4A88-A9AC-E21FD3D3DBB4Q46045279-12099A14-A806-40E3-B9B7-2689BF7ED19AQ46218964-5DBE0099-E3A9-4450-A72C-52A730672301Q47398642-B043D58C-2BFD-4882-8AC6-A2BC0C7F5290Q47591035-CE1E84A4-4F14-433B-943C-62A4D8B03956Q47593433-69553D0D-8AEF-47FF-BBEB-6C4BB9CA0718Q47699286-5EC7EBCE-94DB-4F59-9C1B-9A9F875741EEQ47724955-CBDEB50F-994D-49EA-A985-5C1A72F1005EQ47772325-B1975080-CE23-4320-A10B-D9DD7926525CQ48108799-76366C71-57A3-47CB-8A2C-2499FEFA9E42Q48338684-F699CB05-402F-49F1-8F78-81CB368D7EB4Q48559943-A35DB3A5-534B-4CFC-9D8A-46CE05D64A55Q48584024-254394CF-41EA-4F1C-AC73-3FDA42174595Q49574234-AD724019-3354-4B3B-BD96-8190A17F37EDQ49991922-30784493-2251-415B-85B9-7B88E19A4F85Q50272050-569AC29E-C7D7-466B-802B-C93708D8B687Q50467414-F350BFE3-BD06-4542-96D4-A1D655BA98D7Q50499978-544314E6-7562-49C1-B106-1816646A676DQ50862695-6B5DBB69-F21E-4CA5-8910-67A6692D6B54Q50892468-65D38280-3044-48F0-984D-D68BEB6FBB8BQ51408157-B153A64D-D635-46F9-AEAA-7DC4AC9335B4Q51732221-11E643DB-AF9B-4569-A518-3B021E3F212DQ53088692-593B7BE5-5FA8-47D0-9B77-E46C0C6CDB1CQ53465644-A734403E-E0DF-487B-91CC-E185B2EBDC0CQ53628628-7B7E1034-7273-43CB-B008-F66ACB2337ECQ53744099-7B916692-91CA-45FF-B054-826724FA87C3Q53746326-5EF95AE2-6858-4D8A-99CA-CC19DFAD14E8
P50
description
researcher
@en
wetenschapper
@nl
name
Erwin Ströker
@en
Erwin Ströker
@nl
type
label
Erwin Ströker
@en
Erwin Ströker
@nl
prefLabel
Erwin Ströker
@en
Erwin Ströker
@nl
P31
P496
0000-0001-9094-2576